Concepedia

Mark Cunningham

MC

Statistics

Publications

28

Citations

1.8K

H-Index

21

Active since

1976

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

University of Tennessee Health Science Center

Ironwood Pharmaceuticals (United States)

Mark Cunningham is an author at Bristol-Myers Squibb (United States) specializing in life sciences, immunology, and pharmacology.

ORCID

Publications per year

1976–2019

28

Publications

28

Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain

James R. Burke, Lihong Cheng, Kathleen M. Gillooly et al. · Science Translational Medicine · 2019 · 282 citations

, , +14

A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.

John E. Somerville, Luiza de Paula Silva Cassiano, Brian W. Bainbridge et al. · Journal of Clinical Investigation · 1996 · 274 citations · Full text

, , +13

Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion

Richard P. Darveau, Mark Cunningham, Tina S. Bailey et al. · Infection and Immunity · 1995 · 162 citations · Full text

, , +15

Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer

Nataly Manjarrez‐Orduño, Laurence Ménard, Selena Kansal et al. · Frontiers in Immunology · 2018 · 129 citations · Full text

, , +17

Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo

Richard P. Darveau, Mark Cunningham, Carrie L. Seachord et al. · Antimicrobial Agents and Chemotherapy · 1991 · 102 citations · Full text

, , +9

1–5 of 28